A Double Blind, Double Dummy, Randomized, Placebo-Controlled, 4 Period Cross-Over Study To Examine The Effect Of PF-06372865 On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin As A Positive Control

Trial Profile

A Double Blind, Double Dummy, Randomized, Placebo-Controlled, 4 Period Cross-Over Study To Examine The Effect Of PF-06372865 On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin As A Positive Control

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Dec 2014

At a glance

  • Drugs PF 6372865 (Primary) ; Pregabalin
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
    • 03 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top